公开(公告)号：US20220098162A1

公开(公告)日：2022-03-31

申请号：US17427629

申请日：2020-08-27

申请人： Henan Radiomedical Science and Technology Co., Ltd

发明人： Xuejun Xu ,  Yupo Yang ,  Zhengyan Yang

IPC分类号： C07D295/088

摘要： In view of the lack of anti-cancer targeted drugs in the prior art, the invention provides a naphthylamine compound and a biologically acceptable salt thereof, a preparation method thereof, and an application thereof. The naphthylamine compound and the biologically acceptable salt thereof provided by the invention can bind to protein sites related to tumor diseases in organisms through functional groups in the structure, and have hydrogen bonds and hydrophobic interactions with receptors, so as to achieve the purpose of inhibiting tumor cell proliferation.